NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

路易氏體失智症 (LBD) 治療藥的全球市場 (藥物的各類型、各適應症、各流通管道、各地區):市場佔有率、規模、趨勢分析與未來預測 (2020∼2027年)

Lewy Body Dementia Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Type ; By Indication ; By Distribution Channel; By Regions Segment Forecast, 2020 - 2027

出版商 Polaris Market Research 商品編碼 977357
出版日期 內容資訊 英文 112 Pages
商品交期: 最快1-2個工作天內
價格
路易氏體失智症 (LBD) 治療藥的全球市場 (藥物的各類型、各適應症、各流通管道、各地區):市場佔有率、規模、趨勢分析與未來預測 (2020∼2027年) Lewy Body Dementia Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Type ; By Indication ; By Distribution Channel; By Regions Segment Forecast, 2020 - 2027
出版日期: 2020年12月01日內容資訊: 英文 112 Pages
簡介

全球路易氏體失智症 (LBD) 用治療藥的市場規模,預計至2027年達到53億1000萬美元。

本報告提供全球路易氏體失智症 (LBD) 治療藥的市場相關分析,疾病、產品概要和市場基本結構,主要的推動及阻礙市場要素,產業的向心力,整體市場規模趨勢預測 (以金額、數量為準,過去4年、今後8年份),藥物的各類型、各適應症、各流通管道、各地區的詳細趨勢,主要企業的簡介等資訊彙整,為您概述為以下內容。

目錄

第1章 簡介

第2章 摘要整理

第3章 分析方法

第4章 路易氏體失智症 (LBD) 治療藥:市場分析

  • 概要
  • LBD治療藥市場動態
    • 促進因素和機會
    • 阻礙因素與課題
  • 波特的五力分析
    • 供應商談判力 (中)
    • 新加入企業的威脅 (低)
    • 買主談判力 (中)
    • 替代產品的威脅 (中)
    • 企業間競爭 (高)
  • 大環境分析
  • LBD治療藥市場/產業趨勢

第5章 路易氏體失智症 (LBD) 治療藥市場:藥物的各種類分析

  • 分析的要點
  • 簡介
    • 市場規模:藥物的各類型 (以金額為準,總計12年份)
  • Modafinil
    • 市場規模:各地區 (以金額為準,總計12年份)
  • 膽鹼酯酶抑制劑
  • 苯重氮基鹽
  • 抗精神病藥
  • 抗憂鬱症藥
  • Carbidopa-Levodopa

第6章 路易氏體失智症 (LBD) 治療藥市場:各適應症分析

  • 分析的要點
  • 簡介
    • 市場規模:適應症的各類型 (以金額為準,總計12年份)
  • 帕金森氏症
  • 路易氏體失智症(LBD)

第7章 路易氏體失智症 (LBD) 治療藥市場:各流通管道分析

  • 分析的要點
  • 簡介
    • 市場規模:各流通管道 (以金額為準,總計12年份)
  • 藥妝店
  • 醫院藥局
  • 線上藥局
  • 零售藥局

第8章 路易氏體失智症 (LBD) 治療藥市場:各地區的分析

  • 分析的要點
  • 簡介
    • 市場規模:各地區 (以金額為準,總計12年份)
  • 北美市場
    • 市場規模:藥物的各類型 (以金額為準,總計12年份)
    • 市場規模:各適應症 (以金額為準,總計12年份)
    • 市場規模:各流通管道 (以金額為準,總計12年份)
    • 美國
    • 加拿大
  • 歐洲市場
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 奧地利
  • 亞太地區市場
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
  • 中東、非洲市場
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國 (UAE)
    • 以色列
    • 南非
  • 南美市場
    • 墨西哥
    • 巴西
    • 阿根廷

第9章 競爭情形

  • 事業擴張、企業收購分析
  • 事業聯盟、合作,契約,展示會

第10章 企業簡介

  • Axovant Sciences Ltd.
  • BioArctic AB
  • Eisai Co., Ltd.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Jazz Pharmaceuticals, Inc.
  • Immungenetics AG
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Limited
目錄
Product Code: PM1742

Title:
Lewy Body Dementia Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Modafinil, Cholinesterase Inhibitors, Benzodiazepine, Antipsychotic Drugs, Anti-depressants, and Carbidopa-Levodopa); By Indication [Parkinson's Disease and Dementia with Lewy Bodies (DLB)]; By Distribution Channel; By Regions Segment Forecast, 2020 - 2027.

The global Lewy body dementia treatment market size is predicted to reach USD 5.31 billion by 2027 according to a new study by Polaris Market Research. The report "Lewy Body Dementia Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Type (Modafinil, Cholinesterase Inhibitors, Benzodiazepine, Antipsychotic Drugs, Anti-depressants, and Carbidopa-Levodopa); By Indication [Parkinson's Disease and Dementia with Lewy Bodies (DLB)]; By Distribution Channel; By Regions Segment Forecast, 2020 - 2027" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Lewy body dementia is a progressive disorder associated with dysfunction of the central nervous system and characterized by deposits of alpha-synuclein, a protein in the brain. The unusual deposits in the brain formed Lewy bodies, which can lead to several problems with body movement, thinking, mood, and behavior. Lewy body dementia is the most common disease after Alzheimer's which is rapidly growing and subsequently foster global market growth. Recent developments include the new launches and clinical studies such as LY3154207, ABBV-0805, etc. The launches of drugs are associated with the diagnosis of dementia with Lewy body, Parkinson's, and Alzheimer's diseases which further leads to drive the growth of the global market.

The prominent factors favoring the global market growth include the rising initiatives by the legal and regulatory authorities to develop an effective and safe treatment for the LBD disorder in the patients. For instance, in October 2019, an LBD Association Research Center of Excellence, Georgetown University Medical Center, has taken the initiative to offer 3 clinical trials to devise new methods and treatments for Lewy body dementia and Alzheimer's disease.

Rising incidences of getting affected by Alzheimer's disease and related disorders include vascular dementia, Lewy body dementia, frontotemporal degeneration, and Parkinson's disease has witnessed the surge in demand for the treatment of the patients. The regulatory authorities and researchers are engaged in discovering new methods and solutions to provide effective treatment of the disorder.

For instance, in June 2020, The Harry T. Mangurian, Jr. Foundation and Florida Atlantic University's Schmidt College of Medicine have amalgamated its forces to discover and research medicine to prevent dementia. The grant of USD 3 million will allow FAU's Schmidt College of Medicine to establish a new FAU Center for Brain Health. Furthermore, in July 2020, the Journal of the American Medical Association (JAMA) has published that researchers have formed a new p-tau217 blood test, which is proved to hold remarkable results in the diagnosis of Alzheimer's disease and related disorders in the patients.

Additionally, the rising prevalence of the progressive diseases of dementia has raised the need for effective treatment to treat the disease and prevent risk in the patients which further leads to drive growth. The growing awareness of the symptoms of the disease and the advancement in healthcare technology to develop new methods and drugs for the treatment of patients is likely to surge the market growth.

Market participants such as Mallinckrodt Pharmaceuticals, BioArctic AB, Bausch Health Companies Inc., Sumitomo Dainippon Pharma Co., Ltd., Janssen Pharmaceuticals, Inc., Jazz Pharmaceuticals, Inc., Allergan Plc., Noven Pharmaceuticals, Inc., Takeda Pharmaceutical Company Ltd., Eli Lilly and Company, Eisai Co., Ltd., Novartis AG, GlaxoSmithKline, Pfizer Inc., Teva Pharmaceuticals, Bayer AG, Sanofi AG, and Mylan NV are some of the key players operating in the industry.

Players in the industry are focusing on developing new methods and drugs for LBD, new launches, increasing expansions, collaborations, and partnerships to enhance their market and revenue share. For instance, in August 2020, Proteostasis Therapeutics, Inc. and Yumanity Therapeutics entered into a definitive merger agreement, and after combining they operate under the name Yumanity Therapeutics, Inc. The merger leads to enhance Yumanity's pipeline of innovative, disease-modifying methods and solutions for neurological disorders.

Polaris Market Research has segmented the Lewy Body Dementia Treatment market report on the basis of drug type, indication, distribution channel, and region

Lewy Body Dementia Treatment Market By Drug Type (Revenue - USD Million, 2016 - 2027)

Modafinil

Cholinesterase Inhibitors

Benzodiazepine

Antipsychotic Drugs

Antidepressants

Carbidopa-Levodopa

Lewy Body Dementia Treatment Market By Indication (Revenue - USD Million, 2016 - 2027)

Parkinson's Disease

Dementia with Lewy Bodies (DLB)

Lewy Body Dementia Treatment Market By Distribution Channel (Revenue - USD Million, 2016 - 2027)

Drug Stores

Hospitals Pharmacies

Online Pharmacies

Retail Pharmacies

Lewy Body Dementia Treatment Market By Regional Outlook (Revenue - USD Million, 2016 - 2027)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Spain

Netherlands

Austria

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Central & South America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Lewy Body Dementia Treatment Market Insights

  • 4.1. Lewy Body Dementia Treatment - Industry snapshot
  • 4.2. Lewy Body Dementia Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Prevalence of Lewy body dementia
      • 4.2.1.2. Affordable Treatment Options
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Drug side-effects
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Lewy Body Dementia Treatment Market Industry trends

5. Lewy Body Dementia Treatment Market Assessment by Drug Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • 5.3. Modafinil
    • 5.3.1. Global Lewy Body Dementia Treatment Market, by Modafinil, by Region, 2016 - 2027 (USD Million)
  • 5.4. Cholinesterase Inhibitors
    • 5.4.1. Global Lewy Body Dementia Treatment Market, by Cholinesterase Inhibitors, by Region, 2016 - 2027 (USD Million)
  • 5.5. Benzodiazepine
    • 5.5.1. Global Lewy Body Dementia Treatment Market, by Benzodiazepine, by Region, 2016 - 2027 (USD Million)
  • 5.6. Antipsychotic Drugs
    • 5.6.1. Global Lewy Body Dementia Treatment Market, by Antipsychotic Drugs, by Region, 2016 - 2027 (USD Million)
  • 5.7. Antidepressants
    • 5.7.1. Global Lewy Body Dementia Treatment Market, by Antidepressants, by Region, 2016 - 2027 (USD Million)
  • 5.8. Carbidopa-Levodopa
    • 5.8.1. Global Lewy Body Dementia Treatment Market, by Carbidopa-Levodopa, by Region, 2016 - 2027 (USD Million)

6. Lewy Body Dementia Treatment Market Assessment by Indication

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • 6.3. Parkinson's Disease
    • 6.3.1. Global Lewy Body Dementia Treatment Market, by Parkinson's Disease, By Region, 2016 - 2027 (USD Million)
  • 6.4. Dementia with Lewy Bodies (DLB)
    • 6.4.1. Global Lewy Body Dementia Treatment Market, by Dementia with Lewy Bodies (DLB), by Region, 2016 - 2027 (USD Million)

7. Lewy Body Dementia Treatment Market Assessment by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • 7.3. Drug Stores
    • 7.3.1. Global Lewy Body Dementia Treatment Market, by Drug Stores, by Region, 2016 - 2027 (USD Million)
  • 7.4. Hospitals Pharmacies
    • 7.4.1. Global Lewy Body Dementia Treatment Market, by Hospitals Pharmacies, by Region, 2016 - 2027 (USD Million)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Lewy Body Dementia Treatment Market, by Online Pharmacies, by Region, 2016 - 2027 (USD Million)
  • 7.6. Retail Pharmacies
    • 7.6.1. Global Lewy Body Dementia Treatment Market, by Retail Pharmacies, by Region, 2016 - 2027 (USD Million)

8. Lewy Body Dementia Treatment Market Assessment by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Lewy Body Dementia Treatment Market Assessment, By Geography, 2016 - 2027 (USD Million)
  • 8.3. Lewy Body Dementia Treatment Market - North America
    • 8.3.1. North America: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
    • 8.3.2. North America: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
    • 8.3.3. North America: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.3.4. Lewy Body Dementia Treatment Market - U.S.
      • 8.3.4.1. U.S: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.3.4.2. U.S: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.3.4.3. U.S: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.3.5. Lewy Body Dementia Treatment Market - Canada
      • 8.3.5.1. Canada: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.3.5.2. Canada: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.3.5.3. Canada: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • 8.4. Lewy Body Dementia Treatment Market - Europe
    • 8.4.1. Europe: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
    • 8.4.2. Europe: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
    • 8.4.3. Europe: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.4.4. Lewy Body Dementia Treatment Market - UK
      • 8.4.4.1. UK: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.4.4.2. UK: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.4.4.3. UK: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.4.5. Lewy Body Dementia Treatment Market - France
      • 8.4.5.1. France: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.4.5.2. France: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.4.5.3. France: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.4.6. Lewy Body Dementia Treatment Market - Germany
      • 8.4.6.1. Germany: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.4.6.2. Germany: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.4.6.3. Germany: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.4.7. Lewy Body Dementia Treatment Market - Italy
      • 8.4.7.1. Italy: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.4.7.2. Italy: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.4.7.3. Italy: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.4.8. Lewy Body Dementia Treatment Market - Spain
      • 8.4.8.1. Spain: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.4.8.2. Spain: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.4.8.3. Spain: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.4.9. Lewy Body Dementia Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.4.9.2. Netherlands: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.4.9.3. Netherlands: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.4.10. Lewy Body Dementia Treatment Market - Austria
      • 8.4.10.1. Austria: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.4.10.2. Austria: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.4.10.3. Austria: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • 8.5. Lewy Body Dementia Treatment Market - Asia-Pacific
    • 8.5.1. Asia Pacific: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
    • 8.5.2. Asia Pacific: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
    • 8.5.3. Asia Pacific: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.5.4. Lewy Body Dementia Treatment Market - China
      • 8.5.4.1. China: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.5.4.2. China: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.5.4.3. China: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.5.5. Lewy Body Dementia Treatment Market - India
      • 8.5.5.1. India: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.5.5.2. India: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.5.5.3. India: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.5.6. Lewy Body Dementia Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.5.6.2. Malaysia: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.5.6.3. Malaysia: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.5.7. Lewy Body Dementia Treatment Market - Japan
      • 8.5.7.1. Japan: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.5.7.2. Japan: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.5.7.3. Japan: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.5.8. Lewy Body Dementia Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.5.8.2. Indonesia: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.5.8.3. Indonesia: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.5.9. Lewy Body Dementia Treatment Market - South Korea
      • 8.5.9.1. South Korea: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.5.9.2. South Korea: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.5.9.3. South Korea: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • 8.6. Lewy Body Dementia Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
    • 8.6.2. Middle East & Africa: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
    • 8.6.3. Middle East & Africa: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.6.4. Lewy Body Dementia Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.6.4.2. Saudi Arabia: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.6.4.3. Saudi Arabia: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.6.5. Lewy Body Dementia Treatment Market - UAE
      • 8.6.5.1. UAE: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.6.5.2. UAE: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.6.5.3. UAE: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.6.6. Lewy Body Dementia Treatment Market - Israel
      • 8.6.6.1. Israel: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.6.6.2. Israel: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.6.6.3. Israel: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.6.7. Lewy Body Dementia Treatment Market - South Africa
      • 8.6.7.1. South Africa: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.6.7.2. South Africa: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.6.7.3. South Africa: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • 8.7. Lewy Body Dementia Treatment Market - Latin America
    • 8.7.1. Latin America: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
    • 8.7.2. Latin America: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
    • 8.7.3. Latin America: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.7.4. Lewy Body Dementia Treatment Market - Mexico
      • 8.7.4.1. Mexico: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.7.4.2. Mexico: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.7.4.3. Mexico: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.7.5. Lewy Body Dementia Treatment Market - Brazil
      • 8.7.5.1. Brazil: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.7.5.2. Brazil: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.7.5.3. Brazil: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
    • 8.7.6. Lewy Body Dementia Treatment Market - Argentina
      • 8.7.6.1. Argentina: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
      • 8.7.6.2. Argentina: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
      • 8.7.6.3. Argentina: Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Axovant Sciences Ltd.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Drug Type/Indication Benchmarking
    • 10.1.4. Recent Development
  • 10.2. BioArctic AB
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Drug Type/Indication Benchmarking
    • 10.2.4. Recent Development
    • 10.2.5. RealView Imaging Ltd.
  • 10.3. Eisai Co., Ltd.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Drug Type/Indication Benchmarking
    • 10.3.4. Recent Development
    • 10.3.5. Nanolive SA
  • 10.4. Sumitomo Dainippon Pharma Co., Ltd.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Drug Type/Indication Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Jazz Pharmaceuticals, Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Drug Type/Indication Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Immungenetics AG
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Drug Type/Indication Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Noven Pharmaceuticals, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Drug Type/Indication Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Teva Pharmaceutical Industries Limited
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Drug Type/Indication Benchmarking
    • 10.8.4. Recent Development

List of Tables

  • Table 1 Global Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 2 Global Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 3 Global Lewy Body Dementia Treatment Market, By Distribution Channel, 2016 - 2027 (USD Million)
  • Table 4 Lewy Body Dementia Treatment Market Assessment, By Geography, 2016 - 2027 (USD Million)
  • Table 5 North America: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 6 North America: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 7 North America: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 8 U.S.: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 9 U.S.: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 10 U.S.: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 11 Canada: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 12 Canada: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 13 Canada: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 14 Europe: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 15 Europe: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 16 Europe: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 17 UK: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 18 UK: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 19 UK: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 20 France: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 21 France: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 22 France: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 23 Germany: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 24 Germany: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 25 Germany: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 26 Italy: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 27 Italy: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 28 Italy: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 29 Spain: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 30 Spain: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 31 Spain: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 32 Netherlands: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 33 Netherlands: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 34 Netherlands: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 35 Austria: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 36 Austria: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 37 Austria: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 38 Asia Pacific: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 39 Asia Pacific: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 40 Asia Pacific: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 41 China: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 42 China: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 43 China: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 44 India: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 45 India: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 46 India: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 47 Malaysia: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 48 Malaysia: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 49 Malaysia: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 50 Japan: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 51 Japan: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 52 Japan: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 53 Indonesia: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 54 Indonesia: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 55 Indonesia: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 56 South Korea: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 57 South Korea: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 58 South Korea: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 59 Middle East & Africa: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 60 Middle East & Africa: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 61 Middle East & Africa: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 62 Saudi Arabia: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 63 Saudi Arabia: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 64 Saudi Arabia: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 65 UAE: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 66 UAE: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 67 UAE: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 68 Israel: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 69 Israel: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 70 Israel: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 71 South Africa: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 72 South Africa: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 73 South Africa: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 74 Latin America: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 75 Latin America: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 76 Latin America: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 77 Mexico: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 78 Mexico: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 79 Mexico: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 80 Brazil: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 81 Brazil: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 82 Brazil: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)
  • Table 83 Argentina: Lewy Body Dementia Treatment Market, By Drug Type, 2016 - 2027 (USD Million)
  • Table 84 Argentina: Lewy Body Dementia Treatment Market, By Indication, 2016 - 2027 (USD Million)
  • Table 85 Argentina: Lewy Body Dementia Treatment Market, By End Use, 2016 - 2027 (USD Million)

List of Figures

Figure 1. Market Highlights (2019, Revenue)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Approach

Figure 4. Market by Geography

Figure 6. Porter's Five Forces

Figure 7. Market by Drug Type

Figure 8. Global Lewy Body Dementia Treatment Market, By Drug Type, 2019 & 2027 (USD Million)

Figure 9. Market by Indication

Figure 10. Global Lewy Body Dementia Treatment Market, By Indication, 2019 & 2027 (USD Million)

Figure 11. Market by Distribution Channel

Figure 12. Global Lewy Body Dementia Treatment Market, By Distribution Channel, 2019 & 2027 (USD Million)

Figure 13. Lewy Body Dementia Treatment Market Assessment, By Geography, 2016 - 2027 (USD Million)

Figure 14. Strategic Analysis - Lewy Body Dementia Treatment Market